Phathom Pharmaceuticals, Inc. (PHAT)
Market Open
26 Oct, 07:07 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 79
+0.04
+0.784%
$
559.83M Market Cap
- P/E Ratio
- Div Yield
153,866 Volume
-4.59 Eps
$ 5.74
Previous Close Want to track PHAT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Phathom Pharmaceuticals, Inc. (PHAT) Statistics
Valuation metrics
Market Cap 559.83M
Enterprise value 449.01M
Trailing P/E (ttm) -4.48
Forward P/E -
PEG ratio -0.03
Price/Sales (ttm) 1.94
Price/Book (mrq) -1.4
Enterprise Value/Revenue 1.87
Enterprise Value/EBITDA -12.78
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.48M
Average volume (90 days) 1.45M
Price summary
52-Week low 5.01
52-Week high 18.31
Beta -
50-Day moving average 7.47
200-Day moving average 9.97
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.41%
Operating margin -0.17%
Operational effectiveness
Return on assets -0.3%
Return on equity 0.26%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.86
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.18
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.18
Total debt (mrq) -
Total Debt/Equity (mrq) -0.49
Current ratio (mrq) 1.92%
Book value per share (mrq) -4.11
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
